Crossmark

Thereaputic efficacy of single dose Albendazole against Ascaris lumbricoides, prevalence of re-infection, and its associated factors among school children at Northwest Ethiopia: an open-label trial study

Crossref DOI link: https://doi.org/10.1186/s12879-026-12644-9

Published Online: 2026-01-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Misganaw, Hana

Tamir, Mebratu

Tegegne, Yalewayker

Abriham, Zufan Yiheyis

Berta, Dereje Mengesha

Teketelew, Bisrat Birke

Cherie, Negesse

Gebeyehu, Tsedenya

Chane, Elias

Angelo, Abiy Ayele

Abere, Aberham

Setegn, Abebaw

Eshetu, Tegegne
License Information

Text and Data Mining valid from 2026-01-30

Version of Record valid from 2026-02-24
More Information

Article History

Received: 7 July 2024

Accepted: 16 January 2026

First Online: 30 January 2026

Declarations

:

: Ethical clearance was received from Ethical review committee (ERC) of school of Biomedical and Laboratory science, university of Gondar. Additionally, support letters were collected from the Chuahit district health center and primary school. Moreover, written and oral assents were received from the parents or legal guardians of all children.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below